UK: GlaxoSmithKline to buy out stake in Novartis joint venture
GlaxoSmithKline (GSK), the UK based healthcare multinational, is to buy out its stake in its consumer healthcare venture with Novartis at a cost of $13 billion. The joint venture, which includes the toothpaste brand Sensodyne and painkiller brand Panadol, as well as Nicotinell stop smoking aids, was formed in 2015 as part of Novartis’ portfolio […]